1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Breast Cancer Core Needle Biopsy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Breast Cancer Core Needle Biopsy Market, by Technology
8.1.1. MRI-based Breast Biopsy
8.1.1.1. Market Revenue and Forecast
8.1.2. Ultrasound-based Breast Biopsy
8.1.2.1. Market Revenue and Forecast
8.1.3. Mammography-based (Stereotactic) Breast Biopsy
8.1.3.1. Market Revenue and Forecast
8.1.4. CT-based Breast Biopsy
8.1.4.1. Market Revenue and Forecast
8.1.5. Other Image-Based Breast Biopsy
8.1.5.1. Market Revenue and Forecast
9.1. Breast Cancer Core Needle Biopsy Market, by End-use
9.1.1. Hospitals & Diagnostic Laboratories
9.1.1.1. Market Revenue and Forecast
9.1.2. Pharmaceutical & Biotechnology Companies
9.1.2.1. Market Revenue and Forecast
9.1.3. Academic & Research Institutes
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Technology
10.1.2. Market Revenue and Forecast, by End-use
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Technology
10.1.3.2. Market Revenue and Forecast, by End-use
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Technology
10.1.4.2. Market Revenue and Forecast, by End-use
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology
10.2.2. Market Revenue and Forecast, by End-use
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Technology
10.2.3.2. Market Revenue and Forecast, by End-use
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Technology
10.2.4.2. Market Revenue and Forecast, by End-use
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Technology
10.2.5.2. Market Revenue and Forecast, by End-use
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Technology
10.2.6.2. Market Revenue and Forecast, by End-use
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology
10.3.2. Market Revenue and Forecast, by End-use
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Technology
10.3.3.2. Market Revenue and Forecast, by End-use
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Technology
10.3.4.2. Market Revenue and Forecast, by End-use
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Technology
10.3.5.2. Market Revenue and Forecast, by End-use
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Technology
10.3.6.2. Market Revenue and Forecast, by End-use
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology
10.4.2. Market Revenue and Forecast, by End-use
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Technology
10.4.3.2. Market Revenue and Forecast, by End-use
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Technology
10.4.4.2. Market Revenue and Forecast, by End-use
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Technology
10.4.5.2. Market Revenue and Forecast, by End-use
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Technology
10.4.6.2. Market Revenue and Forecast, by End-use
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology
10.5.2. Market Revenue and Forecast, by End-use
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Technology
10.5.3.2. Market Revenue and Forecast, by End-use
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Technology
10.5.4.2. Market Revenue and Forecast, by End-use
11.1. Intact Medical Corporation
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Ethicon Surgical Technologies
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Gallini SRL
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Hologic, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Leica Biosystems Nussloch GmbH
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Argon Medical Devices
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Encapsule Medical Devices LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cook Medical Incorporated
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Becton, Dickinson and Company
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. C.R. Bard, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
